Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 21857101000001110 | Octreotide 20mg powder and solvent for suspension for injection vials 1 vial (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| 21857201000001115 | Octreotide 20mg powder and solvent for suspension for injection vials 1 vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial | Is a | True | Octreotide 20mg powder and solvent for suspension for injection vials 1 vial | Inferred relationship | Existential restriction modifier | |
| Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial | Is a | True | Octreotide 20mg powder and solvent for suspension for injection vials 1 vial | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets